SEC Form 4 · accession 0001179110-19-000444
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Donoghoe
Officer — SVP, Enterprise Innovation
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Jan 2, 2019 | A | 5,565 | $0.00 | A | 5,565 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities represent restricted stock units granted under the AbbVie 2013 Incentive Stock Program. They vest in annual increments of 1,855 on 01/02/2020, 1,855 on 01/02/2021, and 1,855 on 01/02/2022, and include the right to have stock withheld for tax purposes.